Annual Working Capital
$442.50 M
+$122.88 M+38.44%
December 31, 2024
Summary
- As of March 13, 2025, KYMR annual working capital is $442.50 million, with the most recent change of +$122.88 million (+38.44%) on December 31, 2024.
- During the last 3 years, KYMR annual working capital has risen by +$83.77 million (+23.35%).
- KYMR annual working capital is now at all-time high.
Performance
KYMR Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$442.50 M
-$59.68 M-11.88%
December 31, 2024
Summary
- As of March 13, 2025, KYMR quarterly working capital is $442.50 million, with the most recent change of -$59.68 million (-11.88%) on December 31, 2024.
- Over the past year, KYMR quarterly working capital has increased by +$122.88 million (+38.44%).
- KYMR quarterly working capital is now -11.88% below its all-time high of $502.18 million, reached on September 30, 2024.
Performance
KYMR Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
KYMR Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +38.4% | +38.4% |
| 3 y3 years | +23.4% | +38.4% |
| 5 y5 years | +659.3% | +38.4% |
KYMR Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +38.4% | -11.9% | +41.6% |
| 5 y | 5-year | at high | +659.3% | -11.9% | +659.3% |
| alltime | all time | at high | +1092.6% | -11.9% | +659.3% |
Kymera Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $442.50 M(+38.4%) | $442.50 M(-11.9%) |
| Sep 2024 | - | $502.18 M(+8.4%) |
| Jun 2024 | - | $463.26 M(-3.7%) |
| Mar 2024 | - | $481.12 M(+50.5%) |
| Dec 2023 | $319.63 M(-8.2%) | $319.63 M(+2.3%) |
| Sep 2023 | - | $312.53 M(-5.5%) |
| Jun 2023 | - | $330.80 M(-5.4%) |
| Mar 2023 | - | $349.62 M(+0.4%) |
| Dec 2022 | $348.07 M | $348.07 M(-13.6%) |
| Sep 2022 | - | $402.90 M(+27.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $315.27 M(-8.1%) |
| Mar 2022 | - | $343.04 M(-4.4%) |
| Dec 2021 | $358.73 M(+87.1%) | $358.73 M(-20.1%) |
| Sep 2021 | - | $449.24 M(+75.4%) |
| Jun 2021 | - | $256.12 M(+11.0%) |
| Mar 2021 | - | $230.65 M(+20.3%) |
| Dec 2020 | $191.72 M(+229.0%) | $191.72 M(+0.9%) |
| Sep 2020 | - | $190.08 M(+64.4%) |
| Jun 2020 | - | $115.62 M(+98.4%) |
| Dec 2019 | $58.27 M(+57.1%) | $58.27 M |
| Dec 2018 | $37.10 M | - |
FAQ
- What is Kymera Therapeutics annual working capital?
- What is the all time high annual working capital for Kymera Therapeutics?
- What is Kymera Therapeutics annual working capital year-on-year change?
- What is Kymera Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly working capital year-on-year change?
What is Kymera Therapeutics annual working capital?
The current annual working capital of KYMR is $442.50 M
What is the all time high annual working capital for Kymera Therapeutics?
Kymera Therapeutics all-time high annual working capital is $442.50 M
What is Kymera Therapeutics annual working capital year-on-year change?
Over the past year, KYMR annual working capital has changed by +$122.88 M (+38.44%)
What is Kymera Therapeutics quarterly working capital?
The current quarterly working capital of KYMR is $442.50 M
What is the all time high quarterly working capital for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly working capital is $502.18 M
What is Kymera Therapeutics quarterly working capital year-on-year change?
Over the past year, KYMR quarterly working capital has changed by +$122.88 M (+38.44%)